Amino Acids in a Region of Ataxin-1 Outside of the Polyglutamine Tract Influence the Course of Disease in SCA1 Transgenic Mice

By Skinner P.J.   Vierra-Green C.A.   Emamian E.   Zoghbi H.Y.   Orr H.T.  

NeuroMolecular Medicine, Vol. 1, Iss. 1, 2002-03 ,pp. : 33-42

Humana Press, Inc

Access to resources Recommend Favorite

The Ins and Outs of a Polyglutamine Neurodegenerative Disease: Spinocerebellar Ataxia Type 1 (SCA1)

By Orr H.T.  

Neurobiology of Disease, Vol. 7, Iss. 3, 2000-06 ,pp. : 129-134

Academic Press

Access to resources Recommend Favorite

Reduction of Purkinje Cell Pathology in SCA1 Transgenic Mice by p53 Deletion

By Shahbazian M.D.   Orr H.T.   Zoghbi H.Y.  

Neurobiology of Disease, Vol. 8, Iss. 6, 2001-12 ,pp. : 974-981

Elsevier

Access to resources Recommend Favorite

Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease

By Mori Fumiaki   Tanji Kunikazu   Toyoshima Yasuko   Yoshida Mari   Kakita Akiyoshi   Takahashi Hitoshi   Wakabayashi Koichi  

Acta Neuropathologica, Vol. 123, Iss. 5, 2012-05 ,pp. : 747-749

Springer Publishing Company

Access to resources Recommend Favorite

p35 Deficiency Accelerates HMGB-1-mediated Neuronal Death in the Early Stages of an Alzheimer's disease Mouse Model

By  

Current Alzheimer Research, Vol. 10, Iss. 8, 2013-01 ,pp. : 829-843

Bentham Science Publishers

Access to resources Recommend Favorite